Circadian rhythms and clock genes in psychotic disorders

Israel Journal of Psychiatry and Related Sciences

Volumn 47, Issue 1, 2010, Pages 27-35

  Lamont, Elaine Waddington ^a,b   Coutu, Daniel L ^c   Cermakian, Nicolas ^b   Boivin, Diane B ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953189335     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. Van Someren EJ, Riemersma-Van Der Lek RF. Live to the rhythm, slave to the rhythm. Sleep Med Rev 2007;11:465-484.
2. Boivin DB. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci 2000;25:446-458.
3. Lamont EW, James FO, Boivin DB, Cermakian N. From circadian clock gene expression to pathologies. Sleep Med 2007;8:547-556.
4. Gottesmann C. The dreaming sleep stage: A new neurobiological model of schizophrenia? Neuroscience 2006;140:1105-1115.
5. Aserinsky E, Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 1953;118:273-274.
6. Zarcone V, Azumi K, Dement W, Gulevich G, Kraemer H, Pivik T. REM phase deprivation and schizophrenia II. Arch Gen Psychiatry 1975;32:1431-1436.
7. Zarcone V, Gulevich G, Pivik T, Dement W. Partial REM phase deprivation and schizophrenia. Arch Gen Psychiatry 1968;18:194-202.
8. Bliss EL, Clark LD, West CD. Studies of sleep deprivation-relationship to schizophrenia. AMA Arch Neurol Psychiatry 1959;81:348-359.
9. Benson KL, Zarcone VP, Jr. Schizophrenia. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia, Penn.: Elsevier/Saunders, 2005.
10. Chouinard S, Poulin J, Stip E, Godbout R. Sleep in untreated patients with schizophrenia: A meta-analysis. Schizophr Bull 2004;30:957-967.
11. Madjirova NP, Petrova NS, Delchev NK. Daily rhythmicity of temperature, pulse and blood pressure in schizophrenic patients. Schizophr Res 1995;14:183.
12. Bersani G, Mameli M, Garavini A, Pancheri P, Nordio M. Reduction of night/day difference in melatonin blood levels as a possible disease-related index in schizophrenia. Neuro Endocrinol Lett 2003;24:181-184.
13. Monteleone P, Maj M, Fusco M, Kemali D, Reiter RJ. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr Res 1992;7:77-84.
14. Shamir E, Laudon M, Barak Y, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000;61:373-377.
15. Morgan R, Cheadle AJ. Circadian body temperature in chronic schizophrenia. Br J Psychiatry 1976;129:350-354.
16. Rao ML, Gross G, Strebel B, et al. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry 1994;35:151-163. (Pubitemid 24078480)
17. Wirz-Justice A, Cajochen C, Nussbaum P. A schizophrenic patient with an arrhythmic circadian rest-activity cycle. Psychiatry Res 1997;73:83-90.
18. Wirz-Justice A, Haug HJ, Cajochen C. Disturbed circadian rest-activity cycles in schizophrenia patients: An effect of drugs? Schizophr Bull 2001;27:497-502.
19. Wulff K, Joyce E, Middleton B, Dijk DJ, Foster RG. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: A case report. Chronobiol Int 2006;23:485-495.
20. Mansour HA, Wood J, Chowdari KV, et al. Circadian phase variation in bipolar I disorder. Chronobiol Int 2005;22:571-584.
21. Tandon R. Cholinergic aspects of schizophrenia. Br J Psychiatry Suppl 1999;37:7-11.
22. Jones B. Basic mechanisms of sleep-wake states. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia, Penn.: Elsevier/Saunders, 2005.
23. Behrendt RP. Hallucinations: Synchronisation of thalamocortical gamma oscillations underconstrained by sensory input. Conscious Cogn 2003;12:413-451.
24. Dzirasa K, Ribeiro S, Costa R, et al. Dopaminergic control of sleep-wake states. J Neurosci 2006;26:10577-10589.
25. Abbott A. Restless nights, listless days. Nature 2003;425: 896-898.
26. Katz G, Durst R, Knobler HY. Exogenous melatonin, jet lag, and psychosis: Preliminary case results. J Clin Psychopharmacol 2001;21:349-351.
27. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol 2006;21 :S11-15.
28. Beck-Friis J, Ljunggren JG, Thoren M, von Rosen D, Kjellman BF, Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 1985;10:173-186.
29. Linkowski P, Kerkhofs M, Van Onderbergen A, et al. The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry 1994;51:616-624.
30. Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G. Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 2001;26:411-416.
31. Feldman-Naim S, Turner EH, Leibenluft E. Diurnal variation in the direction of mood switches in patients with rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58: 79-84.
32. 32.Voderholzer U, Weske G, Ecker S, Riemann D, Gann H, Berger M. Neurobiological findings before and during successful lithium therapy of a patient with 48-hour rapid-cycling bipolar disorder. Neuropsychobiology 2002;45:13-19.
33. Leibenluft E, Albert PS, Rosenthal NE, Wehr TA. Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psychiatry Res 1996;63:161-168.
34. Wehr TA. Sleep loss: A preventable cause of mania and other excited states. J Clin Psychiatry 1989;50, Suppl:8-16; discussion 45-47.
35. Benedetti F, Barbini B, Campori E, Fulgosi MC, Pontiggia A, Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: New findings supporting the internal coincidence model? J Psychiatr Res 2001;35:323-329.
36. Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979;206:710-713.
37. Abe M, Herzog ED, Block GD. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 2000;11:3261-3264.
38. Campbell SS, Gillin JC, Kripke DF, Janowsky DS, Risch SC. Lithium delays circadian phase of temperature and REM sleep in a bipolar depressive: A case report. Psychiatry Res 1989;27:23-29.
39. LeSauter J, Silver R. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry 1993;34:75-83. (Pubitemid 23240025)
40. Barbini B, Colombo C, Benedetti F, Campori E, Bellodi L, Smeraldi E. The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res 1998;79:43-50.
41. Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 1992;149:159-168.
42. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis. Am J Psychiatry 1990;147:14-21.
43. Leibenluft E, Turner EH, Feldman-Naim S, Schwartz PJ, Wehr TA, Rosenthal NE. Light therapy in patients with rapid cycling bipolar disorder: preliminary results. Psychopharmacol Bull 1995;31:705-710.
44. Sit D, Wisner KL, Hanusa BH, Stull S, Terman M. Light therapy for bipolar disorder: A case series in women. Bipolar Disord 2007;9:918-927.
45. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: Replication of main effects and interaction. Psychiatry Res 2000;95:43-53.
46. Smeraldi E, Benedetti F, Barbini B, Campori E, Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology 1999;20:380-385.
47. Barbini B, Benedetti F, Colombo C, et al. Dark therapy for mania: A pilot study. Bipolar Disord 2005;7:98-101.
48. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 1998;43:822-828.
49. Leibenluft E, Suppes T. Treating bipolar illness: Focus on treatment algorithms and management of the sleep-wake cycle. Am J Psychiatry 1999;156:1976-1981.
50. Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, Gillin JC. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res 1990;33:129-134.
51. Srinivasan V, Smits M, Spence W, et al. Melatonin in mood disorders. World J Biol Psychiatry 2006;7:138-151.
52. Hallam KT, Olver JS, Horgan JE, McGrath C, Norman TR. Low doses of lithium carbonate reduce melatoninlight sensitivity in healthy volunteers. Int J Neuropsychopharmacol 2005;8:255-259.
53. Gao K, Calabrese JR. Newer treatment studies for bipolar depression. Bipolar Disord 2005;7:13-23.
54. Cermakian N, Boivin DB. A molecular perspective of human circadian rhythm disorders. Brain Res Brain Res Rev 2003;42:204-220.
55. Dardente H, Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int 2007;24:195-213.
56. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006;15:R271-277.
57. Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 1997;91:1055-1064.
58. Albrecht U, Zheng B, Larkin D, Sun ZS, Lee CC. MPer1 and mper2 are essential for normal resetting of the circadian clock. J Biol Rhythms 2001;16:100-104. (Pubitemid 32391905)
59. Gekakis N, Staknis D, Nguyen HB, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-1569.
60. Hogenesch JB, Gu YZ, Jain S, Bradfield CA. The basichelix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci USA 1998;95:5474-5479.
61. Kume K, Zylka MJ, Sriram S, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999;98:193-205.
62. Shearman LP, Sriram S, Weaver DR, et al. Interacting molecular loops in the mammalian circadian clock. Science 2000;288:1013.
63. Preitner N, Damiola F, Lopez-Molina L, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002;110:251-260. (Pubitemid 34876552)
64. Sato TK, Panda S, Miraglia LJ, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004;43:527-537.
65. Ueda HR, Chen W, Adachi A, et al. A transcription factor response element for gene expression during circadian night. Nature 2002;418:534-539.
66. Akashi M, Tsuchiya Y, Yoshino T, Nishida E. Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells. Mol Cell Biol 2002;22:1693-1703.
67. Eide EJ, Woolf MF, Kang H, et al. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasomemediated PER2 degradation. Mol Cell Biol 2005;25:2795-2807.
68. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM. Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. Mol Cell Biol 2000;20:4888-4899.
69. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 2005;280:29397-29402.
70. Gallego M, Virshup DM. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007;8:139-148.
71. DeBruyne JP, Weaver DR, Reppert SM. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat Neurosci 2007;10:543-545.
72. Reick M, Garcia JA, Dudley C, McKnight SL. NPAS2: an analog of clock operative in the mammalian forebrain. Science 2001;293:506-509.
73. Barnes JW, Tischkau SA, Barnes JA, et al. Requirement of mammalian Timeless for circadian rhythmicity. Science 2003;302:439-442.
74. Gotter AL, Manganaro T, Weaver DR, et al. A time-less function for mouse timeless. Nat Neurosci 2000;3:755-756.
75. Gotter AL. A Timeless debate: resolving TIM?s noncircadian roles with possible clock function. Neuroreport 2006;17:1229-1233.
76. James FO, Cermakian N, Boivin DB. Circadian rhythms of melatonin, cortisol, and clock gene expression during simulated night shift work. Sleep 2007;30:1427-1436.
77. Ackermann K, Dehghani F, Bux R, Kauert G, Stehle JH. Day-night expression patterns of clock genes in the human pineal gland. J Pineal Res 2007;43:185-194.
78. Wu YH, Fischer DF, Kalsbeek A, et al. Pineal clock gene oscillation is disturbed in Alzheimer?s disease, due to functional disconnection from the "master clock." Faseb J 2006;20:1874-1876.
79. Kusanagi H, Hida A, Satoh K, et al. Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells. Neurosci Res 2008;61:136-142.
80. Tsinkalovsky O, Smaaland R, Rosenlund B, et al. Circadian variations in clock gene expression of human bone marrow CD34+ cells. J Biol Rhythms 2007;22:140-150.
81. Jones CR, Campbell SS, Zone SE, et al. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med 1999;5:1062-1065.
82. Toh KL, Jones CR, He Y, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001;291:1040-1043.
83. Xu Y, Padiath QS, Shapiro RE, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005;434:640-644.
84. Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 2007;128:59-70.
85. Archer SN, Robilliard DL, Skene DJ, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003;26:413-415.
86. Ebisawa T, Uchiyama M, Kajimura N, et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2001;2:342-346.
87. Jones KH, Ellis J, von Schantz M, Skene DJ, Dijk DJ, Archer SN. Age-related change in the association between a polymorphism in the PER3 gene and preferred timing of sleep and waking activities. J Sleep Res 2007;16:12-16.
88. Viola AU, Archer SN, James LM, et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007;17:613-618.
89. Archer SN, Viola AU, Kyriakopoulou V, von Schantz M, Dijk DJ. Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes. Sleep 2008;31:608-617.
90. Katzenberg D, Young T, Finn L, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep 1998;21:569-576.
91. Mishima K, Tozawa T, Satoh K, Saitoh H, Mishima Y. The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample. Am J Med Genet B Neuropsychiatr Genet 2005;133:101-104.
92. Robilliard DL, Archer SN, Arendt J, et al. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J Sleep Res 2002;11:305-312.
93. Lee HJ, Paik JW, Kang SG, Lim SW, Kim L. Allelic variants interaction of CLOCK gene and G-protein beta3 subunit gene with diurnal preference. Chronobiol Int 2007;24:589-597.
94. Iwase T, Kajimura N, Uchiyama M, et al. Mutation screening of the human Clock gene in circadian rhythm sleep disorders. Psychiatry Res 2002;109:121-128.
95. Takao T, Tachikawa H, Kawanishi Y, Mizukami K, Asada T. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: A preliminary study. Eur Neuropsychopharmacol 2007;17:273-276.
96. Yujnovsky I, Hirayama J, Doi M, Borrelli E, Sassone-Corsi P. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proc Natl Acad Sci USA 2006;103:6386-6391.
97. Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 2004;77:858-866.
98. Mansour HA, Wood J, Logue T, et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 2006;5:150-157.
99. Peng ZW, Chen XG, Wei Z. Cryptochrome1 maybe a candidate gene of schizophrenia. Med Hypotheses 2007;69: 849-851.
100. Gustincich S, Contini M, Gariboldi M, et al. Gene discovery in genetically labeled single dopaminergic neurons of the retina. Proc Natl Acad Sci USA 2004;101:5069-5074.
101. Uz T, Ahmed R, Akhisaroglu M, et al. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 2005;134:1309-1316.
102. Nievergelt CM, Kripke DF, Barrett TB, et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2006;141:234-241.
103. Shiino Y, Nakajima S, Ozeki Y, Isono T, Yamada N. Mutation screening of the human period 2 gene in bipolar disorder. Neurosci Lett 2003;338:82-84.
104. Nievergelt CM, Kripke DF, Remick RA, et al. Examination of the clock gene Cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association. Psychiatr Genet 2005;15:45-52.
105. Yang S, Van Dongen HP, Wang K, Berrettini W, Bucan M. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 2009;14:143-155.
106. Benedetti F, Dallaspezia S, Fulgosi MC, et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007;144B:631-635.
107. Benedetti F, Serretti A, Colombo C, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003;123:23-26.
108. Serretti A, Benedetti F, Mandelli L, et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 2003;121:35-38.
109. Serretti A, Cusin C, Benedetti F, et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 2005;137:36-39.
110. Benedetti F, Radaelli D, Bernasconi A, et al. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav 2008;7:20-25.
111. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007;104:6406-6411.
112. Gould TD, Manji HK. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 2005;30:1223-1237.
113. Quiroz JA, Gould TD, Manji HK. Molecular effects of lithium. Mol Interv 2004;4:259-272.
114. Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms 2007;5:3.
115. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Reverbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006;311:1002-1005.
116. Wirz-Justice A, Benedetti F, Berger M, et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 2005;35:939-944.